|
![]() |
|||
|
||||
OverviewThe pharmaceutical industry is broken. From the American hedge fund manager who hiked the price of an AIDS pill overnight to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and patient care has been distorted to boost profits. Unless we take action we risk a dramatic decline in the pace of drug development and a future in which medicines go to the highest bidder. In Sick Money investigative journalist Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back. '[Sick Money] distinguishes itself from many other books by its investigative power and meticulous clarity' - The Times Full Product DetailsAuthor: Billy KenberPublisher: Canongate Books Imprint: Canongate Books Edition: Main Dimensions: Width: 12.90cm , Height: 2.60cm , Length: 19.80cm Weight: 0.287kg ISBN: 9781838850296ISBN 10: 1838850295 Pages: 432 Publication Date: 07 July 2022 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsBilly Kenber is one of the most promising young journalists in the land, and he has, unsurprisingly, produced a compelling debut which surprises, entertains and inspires dismay. An essential read -- SATHNAM SANGHERA Billy Kenber does a fantastic job, pulling apart the origins of the drugs industry and machinations of its shameless profiteers with surgical precision . . . it's quite a ride. A must-read for anyone who wants to understand how the drugs industry really does its business -- JACQUES PERETTI A forensic and very readable account of the reforms needed to make the pharmaceutical industry serve the public good as well as private profit . . . Kenber's ground-breaking investigative reporting has . . . resulted in a change in the law in the UK, intervention by regulators, cuts in the price of some medicines, life-changing benefits for patients, savings of hundreds of millions of pounds for the NHS and record fines for drug firms -- ANDREW GRICE [Sick Money] distinguishes itself from many other books by its investigative power and meticulous clarity * * The Times * * Powerful, gripping and rigorous, this book couldn't have come at a better time. Never has it been so important to delve into the tangled web behind the medicines and vaccines we all rely on. With years of research and reporting under his belt, Kenber is the perfect person to take us on this fascinating journey -- MAEVE McCLENAGHAN, author of NO FIXED ABODE A clever exploration of a scandal that affects everyone who uses - and pays for - the NHS. This is an enormously complex subject, but Kenber finds the interesting characters and fascinating details that bring the story to life. A great and important read -- HOLLY WATT, author of CASEY BENEDICT series A painstakingly researched and beautifully written history of the dark underbelly of the pharmaceutical industry, which never forgets to tell the stories of the vulnerable people harmed when these companies lose their moral compass. I could not put it down -- NIGEL PRAITIES, executive editor of the PHARMACEUTICAL JOURNAL Author InformationBilly Kenber is an investigative journalist at The Times and has worked at the newspaper since 2010. He has won several accolades including prizes at the UK Press Awards, the British Journalism Awards and two prizes from the Medical Journalists' Association including the 2017 award for Outstanding Contribution to Health or Medical Journalism. In 2013 he won the Laurence Stern Fellowship and worked for the Washington Post for three months. He lives in London. @billykenber Tab Content 6Author Website:Countries AvailableAll regions |